|
Arbor Surgical Technologies |
|
|
610 Palomar Sunnyvale, CA 94085 USA phone:(650) 851-2332 fax:
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.arborsurgical.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Arbor Surgical Technologies, Inc. with facilities located in Irvine and Portola Valley, CA (USA), is a privately held cardiovascular medical device company focused on the heart valve replacement market. |
 |
| Management |
| Thomas J. Fogarty MD, Arbor board chairman and co-founder; Steve Bacich, Arbor President and Chief Executive Officer; Pete Shagory of Baird Venture Partners; David Douglass of Delphi Ventures; Doug Kelly MD of Alloy Ventures; Johnson & Johnson Development Corporation; David Chonette |
| |
|
|
| |
|
| Keywords |
| MedlinePlus, Heart valve surgery, Arbor Surgical, Innovative Development, Hemodynamic performance |
|
|
|
| Description |
|
Arbor Surgical Technologies, Inc. with facilities located in Irvine and Portola Valley, CA (USA), is a privately held cardiovascular medical device company focused on the heart valve replacement market. Founded in 2002 by Dr. Thomas J. Fogarty and noted heart valve designer, Ernie Lane, Arbor is developing multiple technologies that have the potential to deliver significant clinical benefit to patients worldwide. Arbor intends to develop and commercialize its core technologies in varying combinations, giving the company the opportunity to create a broad portfolio of product offerings. Currently in clinical trials, Arbor is developing a tissue heart valve family of products designed for improved performance over existing valves and compatible implantation tools that simplify and speed valve replacement surgery. |
 |
 |
|
|
|
|
|
|